Definitive Contract 75N93022C00027

Award Date 9/30/22
Potential Completion Date 9/29/25
Potential Value $1.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norman, OK 73069, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
Immuno Mycologies Inc. was awarded a $299,593 firm fixed price definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop an easy-to-use diagnostic test capable of early, rapid detection of Talaromyces antigen in human serum, plasma, and/or urine. This contract was awarded under the Small Business Innovation Research Program Phase I solicitation issued by NIH and the Centers for Disease Control and Prevention seeking proposals to...
This federal contract award to Immuno Mycologies Inc., a specialized manufacturer of diagnostic products focused on fungal diseases, provides for the procurement of immunology and mycology supplies. The $171,347.26 firm fixed-price purchase order was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 on January 19, 2025, with a completion date of January 18, 2026. The contract is not set-aside. Immuno Mycologies Inc. is the prime contractor and sole...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) to Immuno Mycologies Inc., a for-profit manufacturer of diagnostic products for fungal diseases. The contract, valued at $72,764.52, is for the procurement of immunology and mycology supplies. Immuno Mycologies Inc. is a critical sole-source supplier of these specialized diagnostic testing materials for the Department of Veterans Affairs (VA) healthcare system. The company has also secured...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
This is a $6,325,163.04 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMMS) for a project titled "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract does not have a set-aside designation. The objective is to conduct research to identify T-cell epitopes of pathogenic fungi including Blastomyces, Coccidioides, Cryptococcus, and...
This Small Business Innovation Research Phase I contract was awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases to Giner Inc. for $299,949. The contract calls for the development of a low-cost and robust nucleic acid sensor instrument that can rapidly and accurately identify the presence of dimorphic fungal species to yield early and definitive diagnosis of endemic fungal diseases such as histoplasmosis and coccidioidomycosis. The contract responds...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 to Immuno Mycologies Inc., a for-profit manufacturer of diagnostic products. The contract, valued at $146,563.23, is for the provision of complement fixation testing controls and reagents. It has an ultimate completion date of January 18, 2025. Immuno Mycologies Inc. is the sole provider for these diagnostic materials under this Indefinite Delivery Contract,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Dxdiscovery Incorporated a $1,469,691 definitive contract to develop an antigen detection immunoassay for Coccidioides galactomannan under a Small Business Innovation Research Program Phase II action. As the prime contractor, Dxdiscovery Inc. will perform the work at its Reno, Nevada location over a three year period concluding on September 29, 2025. The firm...
This is a $599,234 firm fixed price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Celdara Medical, a small business biotechnology company, under the Small Business Innovation Research (SBIR) program. The contract is for research to discover parasite-derived tolerogenic adjuvants, which could potentially be used in new vaccine development. Celdara Medical conducts research and...
This is a $1,488,107.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Tetracore, Inc., a small business based in Rockville, Maryland. The contract is for the Phase II development of a rapid molecular assay for the point-of-care detection of Treponema pallidum, the causative agent of syphilis. This contract was awarded under the Small Business Innovation...

This federal contract award to Immuno Mycologies Inc., a small business manufacturer of diagnostic products, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $1,499,709 firm fixed-price contract is for the development and validation of an enzyme immunoassay (EIA) to detect the Talaromyces marneffei antigen, which causes the fungal disease talaromycosis. This is a Phase II Small Business Innovation Research (SBIR) program contract, building on earlier Phase I work, to create a rapid and accurate in-house diagnostic test. The contract has a completion date of September 29, 2025 and was awarded on September 30, 2022.

Generated 4/25/25, 10:19 AM